Position in ALKS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$157,409
+$89,059 QoQ
Shares Held
3,004
+55.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#310
of 421 holders
Holding Since
Dec 2020
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Pinnacle Wealth Planning Services, Inc. holds $2,537,397 across 33 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
14,002 | $474,387 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
24,879 | $360,496 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
10,089 | $248,290 | |
| 4 | ALKS |
Alkermes plc.
This page
|
3,004 | $157,409 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
3,019 | $140,413 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
13,040 | $130,400 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
3,521 | $122,073 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
7,170 | $114,935 |
All Filings in ALKS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $157,409 | 3,004 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $68,350 | 1,933 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $47,454 | 1,696 | Shares | Sole | 2026-02-13 | |
| 2020-12-31 | $43,111 | 2,161 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||